Effect of Sequential Therapy on Treatment of Helicobacter Pylori Infection in Children

Effect of sequential therapy on treatment of helicobacter pylori in children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201702179101N3

Enrollment

Registered

2017-04-23

Start date

2013-01-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters

Interventions

(Lansoprazol, Amoxicillin) for 5 days and (Lansoprazol, Metronidazole and Clarithromycin) for next 5 days..

Treatment - Drugs

(Lansoprazol, Amoxicillin) for 5 days and (Lansoprazol, Metronidazole and Clarithromycin) for next 5 days.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: age < 18 years; gastrointestinal symptoms with suspected H.pylori infection; abdominal pain; nausea; vomiting; halitosis; gastrointestinal bleeding Exclusion criteria: History of antibiotic consumption

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Eradication of Helicobacter Pylori Infection. Timepoint: Six week after treatment. Method of measurement: Stool antigen.	—

Secondary

Measure	Time frame
Treatment side effect. Timepoint: 6 weeks after treatment. Method of measurement: History and physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Mohsen Dehghani

Shiraz University of Medical Sciences

dehghanism@sums.ac.ir+98 71 3612 5849

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026